Semax Research Hub
Semax is a synthetic heptapeptide derived from the ACTH (adrenocorticotropic hormone) sequence. Originally developed in Russia, it has been studied in neuropeptide research contexts and is of interest to researchers examining cognitive and neurological signalling pathways. This hub provides key research information for laboratory researchers.
All Semax supplied by Precision Chain Peptides is strictly for legitimate laboratory and in-vitro research use only. Not for human or animal administration.
Compound Overview
- Full name: Met-Glu-His-Phe-Pro-Gly-Pro (ACTH(4-7)PGP)
- Molecular formula: C₃₅H₅₁N₁₃O₁₀S
- Molecular weight: 813.95 g/mol
- Format supplied: Lyophilised powder
- Research purity: ≥98% (HPLC verified)
- Storage: -20°C, away from light and moisture
Research Background
Semax has been the subject of published preclinical research examining its interactions with BDNF (Brain-Derived Neurotrophic Factor) expression and neuroprotective pathways in animal models. It is classified as a neuropeptide and is studied alongside other neuropeptide research compounds including Selank and DSIP.
Research Articles
Related Research Category
Semax is classified within our Neuropeptide Research collection, alongside Selank and DSIP.
Supply Information
Precision Chain Peptides supplies Semax 10mg in lyophilised format, HPLC-verified with COA available on request.
View Semax 10mg — Research Peptide
Quality & Documentation
For COA requests, see our Quality & Testing page or contact us.
Research Use Only
All compounds are strictly for legitimate laboratory and in-vitro research use only. See our Research Use Only Policy.